Search - tctmd.com

Displaying 441 - 460 of 768

Sort: Relevancy | Date

News Daily News

Meta-analysis: IVUS-Guided Stent Placement Improves Outcomes vs Angiography

L.A. McKeown

February 17, 2014

News Daily News

Meta Análisis: La Implantación de Stents guiados por IVUS Mejore los Resultados con respecto a la Angiografía

L.A. McKeown

February 17, 2014

News Industry News

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

February 13, 2014

News Daily News

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

January 22, 2014

News Daily News

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

January 22, 2014

Presentation ISET 2014

Ultrasound Enhanced Delivery of Paclitaxel to SFA/POP for CLI Patients

Presenter: Roberto Gandini

January 20, 2014

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Daily News

Los SLF de 2ª Generación son la Mejor Opción para Pacientes víctimas de STEMI

December 09, 2013

Presentation

Preliminary Results from PATENT-C: A RCT Comparing A Paclitaxel-Coated Scoring Balloon to a Standard Balloon in Coronary ISR

Presenter: Gary Gershony

December 01, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

Presentation TCT 2013

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

Presenter: Michael Joner

October 31, 2013

News Conference News TCT 2013

Drug-coated Balloons May Become Standard of Care in ISR

October 31, 2013

Presentation TCT 2013

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

Presenter: Kenneth Rosenfield

October 30, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

News Industry News

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

October 30, 2013

News Conference News TCT 2013

PCI vs. CABG a Close Call in Some Complex Patients

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

Presenter: Michael Haude

October 29, 2013

Presentation TCT 2013

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Presenter: Peter Smits

October 29, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Advertisement

Meta-analysis: IVUS-Guided Stent Placement Improves Outcomes vs Angiography

Meta Análisis: La Implantación de Stents guiados por IVUS Mejore los Resultados con respecto a la Angiografía

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

Ultrasound Enhanced Delivery of Paclitaxel to SFA/POP for CLI Patients

Second-Generation DES the Better Choice for STEMI Patients

Los SLF de 2ª Generación son la Mejor Opción para Pacientes víctimas de STEMI

Preliminary Results from PATENT-C: A RCT Comparing A Paclitaxel-Coated Scoring Balloon to a Standard Balloon in Coronary ISR

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

Drug-coated Balloons May Become Standard of Care in ISR

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

PCI vs. CABG a Close Call in Some Complex Patients

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content